The Latest Analyst Ratings for Olema Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish and somewhat bullish ratings for Olema Pharmaceuticals (NASDAQ:OLMA) in the last quarter. According to 4 analysts offering 12-month price targets in the last 3 months, Olema Pharmaceuticals has an average price target of $19.25, which has increased by 22.85% over the past month.
August 10, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Olema Pharmaceuticals has received bullish ratings from analysts, with an average price target of $19.25, which has increased by 22.85% over the past month.
The bullish ratings and increased price target indicate a positive outlook for Olema Pharmaceuticals. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100